SCHEMBL22978638

SCHEMBL22978638

CCOc1ccnc(CBr)c1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.44
HPGD P15428 3/20 0.44
PDE3A Q14432 2/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 4/20 0.35
LMNA P02545 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 1/20 0.35
MAPK1 P28482 6/20 0.35
TSHR P16473 2/20 0.35
PIP4K2A P48426 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
SQOR Q9Y6N5 1/20 0.35
HTT P42858 1/20 0.35
ADRA2A P08913 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
CHRM1 P11229 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30525604 0.87 SMN1; SMN2 (0.42) SMN1; SMN2HPGDPDE3AALDH1A1KDM4E
SCHEMBL27525988 0.78 HPGD (0.56) SMN1; SMN2HPGDALDH1A1KDM4ELMNA
SCHEMBL3432979 0.77 MAPK1 (0.42) SMN1; SMN2HPGDALDH1A1KDM4ELMNA
SCHEMBL22978501 0.75 HPGD (0.41) SMN1; SMN2HPGDPDE3AALDH1A1KDM4E
SCHEMBL9929711 0.74 MEN1 (0.42) SMN1; SMN2HPGDPDE3AALDH1A1KDM4E
SCHEMBL12843986 0.73 ALDH1A1 (0.50) SMN1; SMN2HPGDALDH1A1KDM4ELMNA
SCHEMBL9834103 0.73 SMN1; SMN2 (0.46) SMN1; SMN2HPGDPDE3AALDH1A1KDM4E
SCHEMBL3076234 0.72 SQOR (0.55) SMN1; SMN2HPGDALDH1A1KDM4ELMNA
SCHEMBL14592934 0.69 ALDH1A1 (0.49) SMN1; SMN2HPGDALDH1A1KDM4ELMNA
SCHEMBL23087507 0.68 PDE3A (0.43) SMN1; SMN2HPGDPDE3AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026672-A1 HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS NOVARTIS AG (CH) 2021-02-18 WO disclosed